PSM-101

N/A

Report date: 2025/02/20 13:46:25

Base Information

Drug NamePSM-101
Drug Alias NamePSM-101PSM101-ADC
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Epidermal growth factor receptor erbB1
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsHead and Neck NeoplasmsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrecisemAb Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPrecisemAb Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsColonic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A